AU3225097A - Immunotherapy for autoimmune disease - Google Patents

Immunotherapy for autoimmune disease

Info

Publication number
AU3225097A
AU3225097A AU32250/97A AU3225097A AU3225097A AU 3225097 A AU3225097 A AU 3225097A AU 32250/97 A AU32250/97 A AU 32250/97A AU 3225097 A AU3225097 A AU 3225097A AU 3225097 A AU3225097 A AU 3225097A
Authority
AU
Australia
Prior art keywords
immunotherapy
autoimmune disease
autoimmune
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU32250/97A
Inventor
Joel R. Haynes
Sudhirdas K. Prayaga
Ian A. Ramshaw
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Auragen Inc
Original Assignee
Auragen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Auragen Inc filed Critical Auragen Inc
Publication of AU3225097A publication Critical patent/AU3225097A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
AU32250/97A 1996-06-03 1997-06-03 Immunotherapy for autoimmune disease Abandoned AU3225097A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1910096P 1996-06-03 1996-06-03
US60019100 1996-06-03
PCT/US1997/009427 WO1997046253A2 (en) 1996-06-03 1997-06-03 Immunotherapy for autoimmune disease

Publications (1)

Publication Number Publication Date
AU3225097A true AU3225097A (en) 1998-01-05

Family

ID=21791438

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32250/97A Abandoned AU3225097A (en) 1996-06-03 1997-06-03 Immunotherapy for autoimmune disease

Country Status (2)

Country Link
AU (1) AU3225097A (en)
WO (1) WO1997046253A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7030098B2 (en) 1999-03-12 2006-04-18 The Board Of Trustees Of The Leland Stanford Junior University DNA vaccination for treatment of autoimmune disease
ES2338890T3 (en) 1999-03-12 2010-05-13 The Board Of Trustees Of The Leland Stanford Junior University DNA VACCINATION FOR THE TREATMENT OF AUTOIMMUNE DISEASES.
US6884785B2 (en) * 1999-06-17 2005-04-26 The Scripps Research Institute Compositions and methods for the treatment or prevention of autoimmune diabetes
IL162077A0 (en) 2001-11-21 2005-11-20 Univ Leland Stanford Junior Polynucleotide therapy the board of trustees of the leland stanford junior university
AU2003294400B2 (en) 2002-11-21 2008-12-18 Bayhill Therapeutics, Inc. Methods and immune modulatory nucleic acid compositions for preventing and treating disease
SE535625C2 (en) 2010-10-28 2012-10-16 Toleranzia Ab New compositions and procedures for the treatment of autoimmune and allergic diseases
WO2013160865A1 (en) 2012-04-26 2013-10-31 Toleranzia Ab Immunotolerizing fusion proteins for treatment of multiple sclerosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2635444B2 (en) * 1990-10-15 1997-07-30 オートイミューン インク Treatment of autoimmune diseases by oral administration of autoantibodies
BR9306042A (en) * 1992-02-28 1997-11-18 Autoimmune Inc Method to treat an autoimmune disease in a mammal and oral and inhalable pharmaceutical dosage forms
WO1995007096A1 (en) * 1993-09-06 1995-03-16 La Trobe University Treatment of autoimmune disease
GB9419553D0 (en) * 1994-09-27 1994-11-16 Univ Bristol Polypeptides and their use in the treatment of auto-immune disease

Also Published As

Publication number Publication date
WO1997046253A3 (en) 1998-01-29
WO1997046253A2 (en) 1997-12-11

Similar Documents

Publication Publication Date Title
AU2677497A (en) Aquaculture system
AU5259398A (en) Hopper
AU1251797A (en) Novel heteroaryl-oxazolidinones
AU4922497A (en) Interleukin-18-receptor proteins
AU6721696A (en) Cd44-like protein
AU3577197A (en) Voice-pager system
AU4005597A (en) Steel-wood system
AU1890597A (en) Improved puzzle-lock compression ring
AU4646097A (en) Improved multiple-burst-correction system
HU9903292D0 (en) Remedy for autoimmune diseases
AUPO169496A0 (en) Termite-proofing system
AU3225097A (en) Immunotherapy for autoimmune disease
AU5250198A (en) Aesthetic imaging system
AU2181197A (en) Connecting part
AU4604397A (en) (o-acyl-p-n-acylamino-phenyl)-o-phosphoethanolamines
AU1900097A (en) Cremators
AU3645097A (en) Chondrocyte proteins
AU3873697A (en) Novel aryl-pyridazines
AU4326397A (en) Novel arylsulfotransferase
AU4505497A (en) Snrnp sm proteins
AU4728597A (en) Headrest
AU1597197A (en) Thienoquinolines
AUPN883396A0 (en) Centrifugation support
AU1643797A (en) Repeater-system
AU742381C (en) Termite-proofing system